cinnabarinic acid has been researched along with purpurin in 1 studies
Studies (cinnabarinic acid) | Trials (cinnabarinic acid) | Recent Studies (post-2010) (cinnabarinic acid) | Studies (purpurin) | Trials (purpurin) | Recent Studies (post-2010) (purpurin) |
---|---|---|---|---|---|
36 | 0 | 19 | 19 | 0 | 12 |
Protein | Taxonomy | cinnabarinic acid (IC50) | purpurin (IC50) |
---|---|---|---|
Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | 6.688 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 5.5 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.8725 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 2.2 | |
Thiosulfate sulfurtransferase | Homo sapiens (human) | 2.3 | |
60 kDa chaperonin | Escherichia coli | 4 | |
10 kDa chaperonin | Escherichia coli | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lefin, R; Petzer, A; Petzer, JP | 1 |
1 other study(ies) available for cinnabarinic acid and purpurin
Article | Year |
---|---|
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship | 2022 |